KATHLEEN LAPORTE - 14 Dec 2022 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Director
Signature
/s/ William P. Quinn, Attorney-in-Fact
Issuer symbol
BOLT
Transactions as of
14 Dec 2022
Net transactions value
$0
Form type
4
Filing time
16 Dec 2022, 12:18:39 UTC
Previous filing
10 Jun 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 14 Dec 2022 Common Stock 25,000 $1.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall be fully vested upon grant date of December 14, 2022.